West Haven, Connecticut 06516

  • Psychotic Disorders


The overarching goal of this study is to characterize the effects of cannabinoids on working and episodic memory.

Study summary:

This study will be achieved by studying the acute effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis and a cannabinoid-1 receptor (CB1R) agonist, on a wide range of memory tasks in healthy human subjects.


Inclusion Criteria: - Men and women aged 18 and 55 years (extremes included) on day of first dosing - Exposed to cannabis at least once in their lifetime Exclusion Criteria: - Cannabis naive - Positive pregnancy screen during screening - Hearing deficits



Primary Contact:

Principal Investigator
Mohini Ranganathan, M.D.
Assistant Professor

Christina Luddy, BS
Phone: 203-932-5711 ext. 4549
Email: christina.luddy@yale.edu

Backup Contact:


Location Contact:

West Haven, Connecticut 06516
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: September 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.